{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:50:43Z","timestamp":1760298643921},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/rhu.0b013e31822541d0","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T17:57:45Z","timestamp":1355767065000},"page":"S50-S56","source":"Crossref","is-referenced-by-count":19,"title":["Multicenter, Open-Label Study of Long-Term Administration of Febuxostat (TMX-67) in Japanese Patients With Hyperuricemia Including Gout"],"prefix":"10.1097","volume":"17","author":[{"given":"Naoyuki","family":"Kamatani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Hada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Kohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210207","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/art.20405","article-title":"A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy.","volume":"51","author":"Shoji","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R2-7-20210207","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/15257770802136040","article-title":"Asymptomatic hyperuricemia: impact of ultrasonography.","volume":"27","author":"Puig","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"R4-7-20210207","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/art.1780080449","article-title":"Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension.","volume":"8","author":"Hall","year":"1965","journal-title":"Arthritis Rheum"},{"key":"R5-7-20210207","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0002-8703(83)90209-0","article-title":"Serum uric acid and coronary heart disease.","volume":"106","author":"Beard","year":"1983","journal-title":"Am Heart J"},{"key":"R6-7-20210207","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.aje.a113972","article-title":"Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study.","volume":"121","author":"Brand","year":"1985","journal-title":"Am J Epidemiol"},{"key":"R7-7-20210207","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0895-4356(88)90127-8","article-title":"Gout and coronary heart disease: the Framingham Study.","volume":"41","author":"Abbott","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"R8-7-20210207","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/jama.1993.03510030102044","article-title":"Uric acid a risk factor for coronary heart disease.","volume":"270","author":"Frohlich","year":"1993","journal-title":"JAMA"},{"key":"R9-7-20210207","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/oxfordjournals.aje.a117479","article-title":"Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I Epidemiologic Follow-up Study.","volume":"141","author":"Freedman","year":"1995","journal-title":"Am J Epidemiol"},{"key":"R10-7-20210207","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2188\/jea.10.403","article-title":"Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers.","volume":"10","author":"Tomita","year":"2000","journal-title":"J Epidemiol"},{"key":"R11-7-20210207","first-page":"437","article-title":"The pharmacology of hypouricemic effect of benzbromarone.","volume":"2","author":"Sinclair","year":"1975","journal-title":"J Rheumatol"},{"key":"R12-7-20210207","first-page":"77","article-title":"Combined therapy using allopurinol and benzbromarone for gout and hyperuricemia complicated with renal disorder.","volume":"4","author":"Hosoya","year":"1992","journal-title":"Jpn J Rheum"},{"key":"R14-7-20210207","first-page":"126","article-title":"Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout.","volume":"76","author":"Rundles","year":"1963","journal-title":"Trans Assoc Am Physicians"},{"key":"R15-7-20210207","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.","volume":"76","author":"Hande","year":"1984","journal-title":"Am J Med"},{"key":"R16-7-20210207","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/S0021-9258(18)63065-0","article-title":"On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo3,4-dpyrimidines.","volume":"245","author":"Massey","year":"1970","journal-title":"J Biol Chem"},{"key":"R17-7-20210207","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0009-8981(69)90052-7","article-title":"Urinary excretion of purines, pyrimidines and pyrazolopyrimidines in patients treated with allopurinol or oxipurinol.","volume":"23","author":"Simmonds","year":"1969","journal-title":"Clin Chim Acta"},{"key":"R18-7-20210207","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(68)90008-9","article-title":"Renal clearance of oxipurinol, the chief metabolite of allopurinol.","volume":"45","author":"Elion","year":"1968","journal-title":"Am J Med"},{"key":"R19-7-20210207","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(93)90201-R","article-title":"Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents.","volume":"241","author":"Osada","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"R20-7-20210207","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1074\/jbc.M208307200","article-title":"An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition.","volume":"278","author":"Okamoto","year":"2003","journal-title":"J Biol Chem"},{"key":"R21-7-20210207","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0014-2999(93)90033-E","article-title":"Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees.","volume":"250","author":"Komoriya","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"R22-7-20210207","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.lfs.2004.10.031","article-title":"Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase\/xanthine dehydrogenase.","volume":"76","author":"Takano","year":"2005","journal-title":"Life Sci"},{"key":"R23-7-20210207","first-page":"307","article-title":"A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase\/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.","volume":"104","author":"Horiuchi","year":"1999","journal-title":"Res Commun Mol Pathol Pharmacol"},{"issue":"suppl","key":"R24-7-20210207","first-page":"S530","article-title":"Phase II dose response clinical trial using febuxostat (TMX-67), a novel-type xanthine oxidase\/xanthine dehydrogenase inhibitor, for gout and hyperuricemia.","volume":"48","author":"Kamatani","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R29-7-20210207","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"R30-7-20210207","first-page":"1501","article-title":"The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.","volume":"27","author":"Lin","year":"2000","journal-title":"J Rheumatol"},{"key":"R31-7-20210207","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-5381-6_3","article-title":"Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment.","volume":"431","author":"Yamanaka","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"R33-7-20210207","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/ken457","article-title":"Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.","volume":"48","author":"Schumacher","year":"2009","journal-title":"Rheumatology (Oxf)"},{"key":"R34-7-20210207","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3899\/jrheum.080814","article-title":"Clinical efficacy and safety of successful long-term urate lowering with febuxostat or allopurinol in subjects with gout.","volume":"36","author":"Becker","year":"2009","journal-title":"J Rheumatol"},{"key":"R35-7-20210207","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.24.691","article-title":"Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects.","volume":"24","author":"Iseki","year":"2001","journal-title":"Hypertens Res"},{"key":"R36-7-20210207","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semnephrol.2004.10.001","article-title":"Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.","volume":"25","author":"Kang","year":"2005","journal-title":"Semin Nephrol"},{"key":"R37-7-20210207","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1681\/ASN.2008010080","article-title":"Elevated uric acid increases the risk for kidney disease.","volume":"19","author":"Obermayr","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R38-7-20210207","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","article-title":"Relationship of uric acid with progression of kidney disease.","volume":"50","author":"Chonchol","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R39-7-20210207","first-page":"407","article-title":"Relationship between hyperuricemia and nephropathy as analyzed from through health checkup data.","volume":"37","author":"Fujimori","year":"1997","journal-title":"Rheumatism"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e31822541d0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:56:01Z","timestamp":1620971761000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201106002-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e31822541d0","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}